Veru Inc. (VERU) stock
VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
$1.94−0.17 (-8.06%)
Close on Nov 20, 2026Market cap $33.08MP/E –Yield –
Veru free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Veru's free cash flow for the twelve months ending Jun 30, 2026 was -$26.04M. For fiscal 2025 it was -$30.04M. The highest annual figure on record is $11.49M in fiscal 2013.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$30.04M | – |
| FY2024 | Sep 30, 2024 | -$21.84M | – |
| FY2023 | Sep 30, 2023 | -$88.68M | – |
| FY2022 | Sep 30, 2022 | -$48.24M | – |
| FY2021 | Sep 30, 2021 | -$15.95M | – |
| FY2020 | Sep 30, 2020 | -$2.04M | – |
| FY2019 | Sep 30, 2019 | -$5.59M | – |
| FY2018 | Sep 30, 2018 | -$11.60M | -1465.3% |
| FY2017 | Sep 30, 2017 | $849.40K | – |
| FY2016 | Sep 30, 2016 | -$1.72M | – |
| FY2015 | Sep 30, 2015 | -$1.68M | -147.2% |
| FY2014 | Sep 30, 2014 | $3.57M | -68.9% |
| FY2013 | Sep 30, 2013 | $11.49M | +19.2% |
| FY2012 | Sep 30, 2012 | $9.64M | +39.2% |
| FY2011 | Sep 30, 2011 | $6.92M | +75.6% |
| FY2010 | Sep 30, 2010 | $3.94M | -4.0% |
| FY2009 | Sep 30, 2009 | $4.10M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$5.47M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$8.91M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$6.17M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$5.49M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$5.48M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$7.74M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$11.33M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$4.43M | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$5.70M | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$5.69M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$6.02M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$9.71M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$18.46M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$25.70M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$34.82M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$21.03M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$14.12M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$4.13M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$8.96M | -1474.1% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$1.03M | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$12.98M | -490.9% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$2.59M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $652.06K | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$373.43K | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $3.32M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$2.45M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$2.53M | – |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | -$988.57K | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$601.93K | -304.2% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$2.82M | -600.2% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$4.59M | -421.3% |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$4.48M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $294.75K | -73.2% |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $563.35K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $1.43M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$2.24M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | $1.10M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$825.60K | – |
See a number that looks wrong?